44 related articles for article (PubMed ID: 11240235)
1. Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review.
Antonarakis ES; Blackford AL; Garrett-Mayer E; Eisenberger MA
J Clin Oncol; 2007 Nov; 25(31):4998-5008. PubMed ID: 17971600
[TBL] [Abstract][Full Text] [Related]
2. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
Pilepich MV; Winter K; Lawton CA; Krisch RE; Wolkov HB; Movsas B; Hug EB; Asbell SO; Grignon D
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1285-90. PubMed ID: 15817329
[TBL] [Abstract][Full Text] [Related]
3. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
Bolla M; Van Tienhoven G; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Billiet I; Torecilla JL; Pfeffer R; Cutajar CL; Van der Kwast T; Collette L
Lancet Oncol; 2010 Nov; 11(11):1066-73. PubMed ID: 20933466
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.
Hanks GE; Pajak TF; Porter A; Grignon D; Brereton H; Venkatesan V; Horwitz EM; Lawton C; Rosenthal SA; Sandler HM; Shipley WU;
J Clin Oncol; 2003 Nov; 21(21):3972-8. PubMed ID: 14581419
[TBL] [Abstract][Full Text] [Related]
5. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.
Bolla M; Collette L; Blank L; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Mattelaer J; Lopez Torecilla J; Pfeffer JR; Lino Cutajar C; Zurlo A; Pierart M
Lancet; 2002 Jul; 360(9327):103-6. PubMed ID: 12126818
[TBL] [Abstract][Full Text] [Related]
6. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
Bolla M; Gonzalez D; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Gil T; Collette L; Pierart M
N Engl J Med; 1997 Jul; 337(5):295-300. PubMed ID: 9233866
[TBL] [Abstract][Full Text] [Related]
7. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.
Denham JW; Steigler A; Lamb DS; Joseph D; Mameghan H; Turner S; Matthews J; Franklin I; Atkinson C; North J; Poulsen M; Christie D; Spry NA; Tai KH; Wynne C; Duchesne G; Kovacev O; D'Este C;
Lancet Oncol; 2005 Nov; 6(11):841-50. PubMed ID: 16257791
[TBL] [Abstract][Full Text] [Related]
8. Short-term versus long-term hormone therapy plus radiotherapy or prostatectomy for prostate cancer: a systematic review and meta-analysis.
Zhou ZR; Zhu XD; Xia J; Zou ZY; Qu S; Zeng XT; Mao Z; Liang ZG
J Cancer Res Clin Oncol; 2013 May; 139(5):783-96. PubMed ID: 23380891
[TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy and intraoperative radiation therapy in high-risk prostate cancer.
Marchioro G; Volpe A; Tarabuzzi R; Apicella G; Krengli M; Terrone C
Adv Urol; 2012; 2012():687230. PubMed ID: 22400019
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art.
Milecki P; Martenka P; Antczak A; Kwias Z
Cancer Manag Res; 2010 Oct; 2():243-53. PubMed ID: 21188116
[TBL] [Abstract][Full Text] [Related]
11. Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy.
Beasley M; Williams SG; Pickles T;
Radiat Oncol; 2008 Apr; 3():8. PubMed ID: 18423030
[TBL] [Abstract][Full Text] [Related]
12. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.
Kumar S; Shelley M; Harrison C; Coles B; Wilt TJ; Mason MD
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006019. PubMed ID: 17054269
[TBL] [Abstract][Full Text] [Related]
13. Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study.
Ganswindt U; Budach W; Jendrossek V; Becker G; Bamberg M; Belka C
Radiat Oncol; 2006 Apr; 1():9. PubMed ID: 16722607
[TBL] [Abstract][Full Text] [Related]
14. 70 Gy or more: which dose for which prostate cancer?
Ganswindt U; Paulsen F; Anastasiadis AG; Stenzl A; Bamberg M; Belka C
J Cancer Res Clin Oncol; 2005 Jul; 131(7):407-19. PubMed ID: 15887028
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.
Eng TY; Luh JY; Thomas CR
Curr Urol Rep; 2005 May; 6(3):194-209. PubMed ID: 15869724
[TBL] [Abstract][Full Text] [Related]
16. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.
Dearnaley DP; Hall E; Lawrence D; Huddart RA; Eeles R; Nutting CM; Gadd J; Warrington A; Bidmead M; Horwich A
Br J Cancer; 2005 Feb; 92(3):488-98. PubMed ID: 15685244
[TBL] [Abstract][Full Text] [Related]
17. Early versus late hormonal therapy for prostate cancer.
Miyamoto H; Messing EM
Curr Urol Rep; 2004 Jun; 5(3):188-96. PubMed ID: 15161567
[TBL] [Abstract][Full Text] [Related]
18. Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy.
Horwitz EM; Winter K; Hanks GE; Lawton CA; Russell AH; Machtay M
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):947-56. PubMed ID: 11240235
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation.
Anderson PR; Hanlon AL; Movsas B; Hanks GE
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1025-30. PubMed ID: 9392540
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]